Dividends Calendar Earnings Calendar
CBAY

CBAY | Cymabay Therapeutics Inc

Cymabay Therapeutics Inc
Category: Consumer goods
  • Industry: Biotechnology

Quick infos

  • Headquarters:   Newark, California, United States

Trade prices

  • Volume:
  • Market Cap: 234.56M
  • Prev closed:
  • Open: 3.04
  • High: 3.2
  • Low: 3.04
  • 52 week low: 2.67
  • 52 week high: 5.13
  • Dividends:No Dividends

Next ER: November 14, 2022  After Market Closes



Top Stories (CBAY)

    Company Profile

    We are a clinical-stage biopharmaceutical company focused on developing and providing access to innovative therapies for patients with liver and other chronic diseases with high unmet medical need. We are evaluating seladelpar in primary biliary cholangitis (PBC). We also have a product program in earlier development that features a unique mechanism of action with potential in chronic diseases.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    March 16, 2023
    November 14, 2022-0.28 / -0.3- / -
    August 11, 2022-0.31 / -0.2988- / -
    May 12, 2022-0.32 / -0.31- / -
    March 17, 2022-0.34 / -0.2613- / 6.43M
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Aug 11, 2022 3.740 4.200
    4.230
    3.730
    794.78K -10.1%
    Aug 10, 2022 4.160 4.150
    4.235
    4.009
    363.46K 1.96%
    Aug 9, 2022 4.080 4.010
    4.090
    3.820
    624.33K 1.24%
    Aug 8, 2022 4.030 4.250
    4.300
    4.020
    801.34K -5.18%
    Aug 5, 2022 4.250 4.100
    4.250
    4.029
    465.75K 3.16%
    Aug 4, 2022 4.120 4.000
    4.200
    3.930
    924.80K 5.64%
    Aug 3, 2022 3.900 3.530
    4.090
    3.499
    1.45M 12.07%
    Aug 2, 2022 3.480 3.200
    3.500
    3.185
    1.38M 8.41%
    Aug 1, 2022 3.210 3.130
    3.340
    3.070
    632.54K 2.56%
    Jul 29, 2022 3.130 3.180
    3.185
    3.080
    230.37K -2.19%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:1988
    • Employees:59

    News

    News for (CBAY)

    This company doesn't provide a dividend.


    Talk about Cymabay Therapeutics Inc below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Nov 14, 2022 (Same day)

    tsn xray qfin cig ortx acst sndl tsem xp trq nby ptn 


    Jump to (Finance sites)

    Research 


    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 100
    HOLD 0
    SELL 0

    Their Official Profiles 

    TwitterFacebookLinkedIn

    Peers / Similar stocks 

    xlv 

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    Technical Analysis For Dummies
    Buy on Amazon

    Technical analysis is a collection of techniques designed to help you make trading decisions in securities markets. Technical Analysis For Dummies helps you take a hard-headed look at what securities prices are actually doing rather than what economists or analysts say they should be doing, giving you the know-how to use that data to decide whether to buy or sell individual securities.

    A simple, straightforward guide to the fundamentals of technical analysis